JP2021531038A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021531038A5 JP2021531038A5 JP2021523576A JP2021523576A JP2021531038A5 JP 2021531038 A5 JP2021531038 A5 JP 2021531038A5 JP 2021523576 A JP2021523576 A JP 2021523576A JP 2021523576 A JP2021523576 A JP 2021523576A JP 2021531038 A5 JP2021531038 A5 JP 2021531038A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- protein construct
- liquid
- patient
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862697691P | 2018-07-13 | 2018-07-13 | |
| US62/697,691 | 2018-07-13 | ||
| US201862719751P | 2018-08-20 | 2018-08-20 | |
| US62/719,751 | 2018-08-20 | ||
| PCT/US2019/041564 WO2020014588A1 (en) | 2018-07-13 | 2019-07-12 | System and method for modulating stress granule assembly |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021531038A JP2021531038A (ja) | 2021-11-18 |
| JP2021531038A5 true JP2021531038A5 (enExample) | 2022-12-06 |
Family
ID=69142650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021523576A Pending JP2021531038A (ja) | 2018-07-13 | 2019-07-12 | ストレス顆粒集合を調節するためのシステム及び方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12195768B2 (enExample) |
| EP (1) | EP3820494A4 (enExample) |
| JP (1) | JP2021531038A (enExample) |
| CN (1) | CN112423781A (enExample) |
| WO (1) | WO2020014588A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021531038A (ja) | 2018-07-13 | 2021-11-18 | ザ、トラスティーズ オブ プリンストン ユニバーシティ | ストレス顆粒集合を調節するためのシステム及び方法 |
| CN113214361B (zh) * | 2021-06-10 | 2022-06-10 | 浙江师范大学 | 一类包含fgdf基序的应激颗粒抑制剂及其应用 |
| CN113135987B (zh) * | 2021-06-10 | 2022-07-12 | 浙江师范大学 | 一类来源于Caprin1的活性肽及其应用 |
| JP2025509601A (ja) * | 2022-03-14 | 2025-04-11 | エフ． ホフマン－ラ ロシュ アーゲー | Ｔａｕ関連疾患の処置のためのＧ３ＢＰ２－Ｔａｕ相互作用のモジュレーター |
| EP4269424A1 (en) * | 2022-04-25 | 2023-11-01 | Københavns Universitet | Novel antiviral compounds and use thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPR721101A0 (en) * | 2001-08-23 | 2001-09-13 | University Of Queensland, The | Nucleic acid and polypeptide linked to breast cancer |
| JPWO2007132555A1 (ja) * | 2006-05-11 | 2009-09-24 | 国立大学法人 東京大学 | 細胞膜透過性ペプチドと細胞内におけるその使用 |
| US20150045330A1 (en) | 2012-01-17 | 2015-02-12 | Kyoto University | Prophylactic and therapeutic drug for amyotrophic lateral sclerosis and method of screening therefor |
| JP6340366B2 (ja) * | 2012-07-31 | 2018-06-06 | イェダ リサーチ アンド デベロップメント カンパニー リミテッド | 運動ニューロン疾患を診断および処置する方法 |
| GB201318954D0 (en) | 2013-10-28 | 2013-12-11 | Cupid Peptide Company Ltd | Cell transport |
| CA3005968A1 (en) | 2015-11-23 | 2017-06-01 | The Regents Of The University Of California | Tracking and manipulating cellular rna via nuclear delivery of crispr/cas9 |
| WO2017161096A1 (en) * | 2016-03-16 | 2017-09-21 | Tarveda Therapeutics, Inc. | Antibody mimic conjugates and particles |
| US10668128B2 (en) * | 2017-02-15 | 2020-06-02 | University Of South Carolina | Targeting G3BP proteins to accelerate nerve regeneration |
| WO2018215597A1 (en) * | 2017-05-24 | 2018-11-29 | Orphazyme A/S | Heat shock protein inducers and frontotemporal disorders |
| US10526380B2 (en) * | 2017-10-26 | 2020-01-07 | St. Jude Children's Research Hospital | Fusion protein and nucleic acid molecule for light-dependent stress granule assembly |
| JP2021531038A (ja) | 2018-07-13 | 2021-11-18 | ザ、トラスティーズ オブ プリンストン ユニバーシティ | ストレス顆粒集合を調節するためのシステム及び方法 |
-
2019
- 2019-07-12 JP JP2021523576A patent/JP2021531038A/ja active Pending
- 2019-07-12 US US17/258,783 patent/US12195768B2/en active Active
- 2019-07-12 CN CN201980046655.3A patent/CN112423781A/zh active Pending
- 2019-07-12 WO PCT/US2019/041564 patent/WO2020014588A1/en not_active Ceased
- 2019-07-12 EP EP19833830.3A patent/EP3820494A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021531038A5 (enExample) | ||
| Albertini et al. | Crystal structure of the rabies virus nucleoprotein-RNA complex | |
| JP2022002530A (ja) | ウイルスベクター効率を改善するための組成物及び方法 | |
| CN112040988A (zh) | 修饰的aav衣壳多肽用于治疗肌肉疾病 | |
| JP2014515602A5 (enExample) | ||
| JP2010516758A5 (enExample) | ||
| JP2012503026A5 (enExample) | ||
| JP2013541335A5 (enExample) | ||
| RU2017134456A (ru) | Рекомбинантные связывающие белки и их применение | |
| RU2010127156A (ru) | Антитела против вируса гриппа и их применение | |
| JP2015518479A5 (enExample) | ||
| Wang et al. | The proline-rich domain and the microtubule binding domain of protein tau acting as RNA binding domains | |
| WO2012125652A2 (en) | Antibody and antibody mimetic for visualization and ablation of endogenous proteins | |
| Stephens et al. | A functional analysis of Wnt inducible signalling pathway protein− 1 (WISP-1/CCN4) | |
| JP2023528204A5 (enExample) | ||
| JP2015504299A5 (enExample) | ||
| JP2024514266A5 (enExample) | ||
| CN102229932B (zh) | 可识别hcv e1e2蛋白的核酸适体、核酸适体的衍生物及其筛选方法和应用 | |
| JP2025539722A (ja) | 抗体を切断する酵素を含む組成物およびそれを使用する方法 | |
| JP2014517690A5 (enExample) | ||
| Qin et al. | Leader RNA regulates snakehead vesiculovirus replication via interacting with viral nucleoprotein | |
| CN104721811B (zh) | 多肽在制备防治脑胶质瘤药物中的应用 | |
| JP2006524491A5 (enExample) | ||
| TW202315879A (zh) | 胜肽標籤與編碼該胜肽標籤之核酸 | |
| CN104611343B (zh) | 分离的鲤抗病毒天然免疫蛋白trim32及抗病毒活性 |